Also
https://www.fiercepharma.com/pharma/keytruda-taught-merck-how-build-blockbuster-manufacturing-second-lightning-bolt-easier-said
Merck have until 2028 to find how to extend the patents by the use of a Keytruda combo. Good timing for IMM. But Merck will not wait until the last seconds of 2027. Any early results during 2025-26 will trigger a buy out IMO.
Alsohttps://www.fiercepharma.com/pharma/keytruda-taught-merck-how...
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.010(3.17%) |
Mkt cap ! $443.6M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.8¢ | 30.5¢ | $1.050M | 3.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 334744 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 5285 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |